Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 14

1.

Interaction of TiO2 nanoparticles with proteins from aquatic organisms: the case of gill mucus from blue mussel.

Bourgeault A, Legros V, Gonnet F, Daniel R, Paquirissamy A, Bénatar C, Spalla O, Chanéac C, Renault JP, Pin S.

Environ Sci Pollut Res Int. 2017 May;24(15):13474-13483. doi: 10.1007/s11356-017-8801-3. Epub 2017 Apr 7.

PMID:
28390017
2.

Genome and Proteome Analysis of Rhodococcus erythropolis MI2: Elucidation of the 4,4´-Dithiodibutyric Acid Catabolism.

Khairy H, Meinert C, Wübbeler JH, Poehlein A, Daniel R, Voigt B, Riedel K, Steinbüchel A.

PLoS One. 2016 Dec 15;11(12):e0167539. doi: 10.1371/journal.pone.0167539. eCollection 2016.

3.

Efficient recovery of glycosaminoglycan oligosaccharides from polyacrylamide gel electrophoresis combined with mass spectrometry analysis.

Bodet PE, Salard I, Przybylski C, Gonnet F, Gomila C, Ausseil J, Daniel R.

Anal Bioanal Chem. 2017 Feb;409(5):1257-1269. doi: 10.1007/s00216-016-0052-5. Epub 2016 Nov 10.

PMID:
27832303
4.

Use of Anticoagulants and Antiplatelet Agents in Stable Outpatients with Coronary Artery Disease and Atrial Fibrillation. International CLARIFY Registry.

Fauchier L, Greenlaw N, Ferrari R, Ford I, Fox KM, Tardif JC, Tendera M, Steg PG; CLARIFY Investigators.

PLoS One. 2015 Apr 27;10(4):e0125164. doi: 10.1371/journal.pone.0125164. eCollection 2015.

5.

Impact of chronic kidney disease on use of evidence-based therapy in stable coronary artery disease: a prospective analysis of 22,272 patients.

Kalra PR, García-Moll X, Zamorano J, Kalra PA, Fox KM, Ford I, Ferrari R, Tardif JC, Tendera M, Greenlaw N, Steg PG; CLARIFY Investigators.

PLoS One. 2014 Jul 22;9(7):e102335. doi: 10.1371/journal.pone.0102335. eCollection 2014.

6.

Heart rate and use of beta-blockers in stable outpatients with coronary artery disease.

Steg PG, Ferrari R, Ford I, Greenlaw N, Tardif JC, Tendera M, Abergel H, Fox KM; CLARIFY Investigators.

PLoS One. 2012;7(5):e36284. doi: 10.1371/journal.pone.0036284. Epub 2012 May 3.

7.
8.

A pepstatin-insensitive aspartic proteinase from a thermophilic Bacillus sp.

Toogood HS, Prescott M, Daniel RM.

Biochem J. 1995 May 1;307 ( Pt 3):783-9.

9.

Characterization of a chelator-resistant proteinase from Thermus strain Rt4A2.

Freeman SA, Peek K, Prescott M, Daniel R.

Biochem J. 1993 Oct 15;295 ( Pt 2):463-9.

10.
11.

Thermostable beta-glucosidase and beta-xylosidase from Thermotoga sp. strain FjSS3-B.1.

Ruttersmith LD, Daniel RM.

Biochim Biophys Acta. 1993 Feb 13;1156(2):167-72.

PMID:
8427876
12.

Purification and characterization of a thermostable proteinase isolated from Thermus sp. strain Rt41A.

Peek K, Daniel RM, Monk C, Parker L, Coolbear T.

Eur J Biochem. 1992 Aug 1;207(3):1035-44.

14.

An extremely thermostable xylanase from the thermophilic eubacterium Thermotoga.

Simpson HD, Haufler UR, Daniel RM.

Biochem J. 1991 Jul 15;277 ( Pt 2):413-7.

Supplemental Content

Loading ...
Support Center